Blackbaud Form 4: Talvitie Awarded 3,670 Shares, No Sales Reported
Rhea-AI Filing Summary
Blackbaud, Inc. (BLKB) director Kristian Talvitie has filed a Form 4 disclosing receipt of 3,670 shares of company common stock on 1 Aug 2025. The shares were granted as a restricted stock award with no purchase price. They will vest in full on 1 Aug 2026 or, if earlier, immediately before the company’s 2026 annual director election, provided Talvitie continues to serve on the board.
Following the grant, Talvitie’s directly held stake increases to 8,053 shares. No derivative securities were reported and there were no sales or dispositions. Because this is a routine, compensation-related award rather than an open-market purchase, the filing has limited signalling impact for investors, though it modestly raises insider alignment.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director grant; neutral fundamental impact.
The 3,670-share restricted stock grant increases Talvitie’s direct holdings by roughly 84%. However, it is standard board compensation with a one-year vest, so it does not convey incremental information about management’s view on valuation. No cash changed hands and there is no dilution beyond the company’s existing equity comp plan. Overall, the filing neither alters BLKB’s capital structure nor signals a change in outlook; therefore, it is best regarded as compliance-driven disclosure.
TL;DR: Grant sustains board-shareholder alignment, impact minimal.
Restricted stock awards are typical for outside directors and help align incentives without encouraging short-term risk taking. A single-tranche, one-year vest period keeps ownership levels visible while maintaining retention pressure through the 2026 AGM. The size of the award is modest versus Blackbaud’s ~52 m shares outstanding, so governance ramifications are negligible. Investors should not interpret this as a bullish signal, but sustained insider ownership can marginally reduce agency concerns.
FAQ
How many Blackbaud (BLKB) shares did director Kristian Talvitie acquire?
What is the vesting schedule for the new BLKB restricted stock grant?
Did the transaction involve any cash payment?
What is Kristian Talvitie’s total direct BLKB share ownership after the grant?
Does the Form 4 report any sales or derivative transactions?